Healthcare
Lantern Pharma Reports Phase 2 HARMONIC Trial Data Showing LP-300 Benefit in EGFR-Mutant Lung Cancer
Lantern Pharma announced updated Phase 2 data for LP-300 in EGFR L858R-mutant non-small cell lung cancer, showing improved progression-free survival and a clean safety profile, with an FDA-cleared protocol amendment extending dosing to eight cycles.
Oncotelic Therapeutics Featured in BioMedWire Editorial Highlighting Advanced Drug Delivery Technologies in Cancer Therapy
Oncotelic Therapeutics is highlighted in a BioMedWire editorial for its focus on advanced drug delivery technologies, including nanoparticle systems and AI-enhanced platforms, to improve cancer therapy efficacy.
Oncotelic Therapeutics Advances Nanotech Drug Delivery Platform for Oncology and Rare Diseases
Oncotelic Therapeutics' inclusion in a BioMedWire editorial highlights the growing industry focus on advanced drug delivery technologies, with its Sapu003 program and Deciparticle platform exemplifying nanotechnology and AI-driven approaches to improve cancer therapy efficacy.
Quantum BioPharma Highlights Lucid-MS and unbuzzd Growth Opportunities in BioMedWire Podcast
Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) was featured on The BioMedWire Podcast, where co-founder Anthony Durkacz discussed the company's lead drug candidate Lucid-MS for multiple sclerosis and its commercial alcohol metabolism product unbuzzd, emphasizing upcoming Phase 2 trials and revenue potential.
HeartBeam's Portable ECG Device Shows Promise in Identifying Heart Attack Risk, Study Finds
A peer-reviewed study published in JACC: Advances demonstrates that HeartBeam's credit card-sized ECG device, combined with a risk prediction algorithm, can accurately identify heart attack risk in chest pain patients, with accuracy rising to 92.9% when a baseline ECG is available.
Quantum BioPharma Highlights Lucid-MS and unbuzzd Growth Potential in BioMedWire Podcast
Quantum BioPharma's co-founder discusses the unmet need in multiple sclerosis treatment with Lucid-MS and the commercial potential of unbuzzd, as the company prepares for a Phase 2 trial.
Ocumetics Strengthens Balance Sheet with $1.4 Million Debt Conversion Ahead of Key Clinical Milestones
Ocumetics Technology Corp. converts $1.4 million of debenture principal into equity, reducing debt by 35% and improving financial flexibility as it prepares for FDA submission.
LataMed AI to Discuss Digital Health Strategy and Latin America Expansion in Upcoming Interview
LataMed AI Corp. (OTC: LMED) is finalizing an exclusive live-streamed interview to present its telehealth and AI initiatives for emerging markets, highlighting the growing role of digital healthcare in Latin America.
iOrganBio Adds Leading Neurobiologist Dr. Zhiping Pang to Scientific Advisory Board
iOrganBio appoints Dr. Zhiping Pang, a top expert in human neuron biology and neuropsychiatric disorders, to its Scientific Advisory Board, strengthening its position in AI-enabled human cell manufacturing for research and therapeutics.
Oncotelic Therapeutics Maintains $388M JV Valuation Amid Biotech Market Volatility
Oncotelic Therapeutics reported a stable $388 million fair value for its 45% stake in GMP Biotechnology, highlighting its partnership-driven model as a buffer against typical biotech cash burn pressures.
Nightfood Holdings Subsidiary TechForce Deploys Autonomous Lab Robot in Pharmaceutical Automation Milestone
TechForce Robotics successfully deployed LIM-E, an autonomous laboratory robot, marking its first expansion into pharmaceutical automation and validating its AI platform's adaptability beyond hospitality.
Regentis Biomaterials Nears Key Milestones for Simplified Cartilage Repair Implant
Regentis Biomaterials advances GelrinC, a single-step hydrogel implant for knee cartilage repair, targeting a $3 billion U.S. market with CE Mark approval and a Phase III trial over 50% enrolled.
Houston Texans and American Heart Association Train Youth Sports Coaches in CPR, Addressing Leading Cause of Death for Student-Athletes
The Houston Texans partnered with the American Heart Association to train nearly 100 youth sports coaches in CPR and AED use, addressing the fact that sudden cardiac arrest is a leading cause of death for student-athletes.
Encinitas Practice Integrates Pediatric Dentistry and Orthodontics for Streamlined Family Care
Encinitas Pediatric Dentistry & Orthodontics has launched an integrated model combining pediatric dentistry and orthodontic services under one roof, simplifying care coordination for families and offering treatments like braces, Invisalign, and clear aligners for children, teens, and adults.
Smart Strategies for Affordable Dental Implants Without Sacrificing Quality
A guide reveals how patients can find cost-effective dental implants through clinic comparisons, financing, and careful provider selection, emphasizing long-term value over upfront savings.
Elite Orthodontics Expands Service to Bowie and Washington, DC, Offering Braces and Invisalign
Elite Orthodontics now serves patients in both Bowie, Maryland and Washington, DC, providing a full range of orthodontic treatments including braces and Invisalign under one roof, which simplifies access to care for families and individuals.
Elite Orthodontics Expands Braces and Invisalign Services to Washington DC
Elite Orthodontics has expanded its full orthodontic services to Washington DC, offering both traditional braces and Invisalign clear aligners to meet patient demand across the region.
Elite Orthodontics Expands Services to Glenn Dale, MD, Offering Braces and Invisalign
Elite Orthodontics has expanded its orthodontic services to Glenn Dale, MD, providing braces and Invisalign options to make personalized care more accessible for families in the region.
Nightfood Subsidiary Deploys Autonomous Lab Robot in Pharmaceutical Automation Milestone
Nightfood Holdings subsidiary TechForce Robotics has deployed its first autonomous lab robot, LIM-E, under a joint agreement with Oncotelic Therapeutics, marking an expansion into pharmaceutical automation and validating its AI platform beyond hospitality.
American Heart Association Brings Hands-Only CPR Training to FIFA Fan Festivals in Four U.S. Host Cities
The American Heart Association will teach Hands-Only CPR at FIFA Fan Festivals in Atlanta, Dallas, Philadelphia, and New York, aiming to equip thousands with lifesaving skills during the global soccer tournament.
Advanced Drug Delivery Technologies Gain Traction as Biotech Firms Seek to Improve Existing Cancer Treatments
Biotechnology companies are increasingly focusing on advanced delivery technologies to enhance existing cancer therapies, with Oncotelic Therapeutics advancing its Deciparticle platform, reflecting a broader industry shift toward scalable nanotechnology and AI-driven drug delivery.
Oncotelic Therapeutics Advances Drug-Delivery Platform as Industry Focuses on Enhancing Existing Therapies
Oncotelic Therapeutics is progressing its Sapu003 program and Deciparticle platform to improve oncology drug delivery and bioavailability, aligning with industry trends favoring advanced delivery technologies over new compound development.
American Heart Association Urges LGBTQ+ Communities to Learn Hands-Only CPR During Pride Month
The American Heart Association is encouraging LGBTQ+ communities and allies to learn Hands-Only CPR this June, citing disparities in heart health and the potential to save lives.
Helus Pharma to Present at Jefferies Global Healthcare Conference Amid Key Clinical Milestones
Helus Pharma, a clinical-stage pharmaceutical company developing novel serotonergic agonists for mental health conditions, will participate in a fireside chat at the Jefferies Global Healthcare Conference, highlighting its Phase 3 and Phase 2 programs for major depressive disorder and generalized anxiety disorder.
Huntsville IT Firm Expands HIPAA Compliance Services for Healthcare
Interweave Technologies, a minority-owned IT firm in Huntsville, Alabama, has expanded its HIPAA compliance and managed cybersecurity services for healthcare organizations, addressing the challenge of meeting federal requirements without dedicated IT staff.
Strawberry Fields REIT to Present at Planet MicroCap Las Vegas 2026, Highlighting Healthcare Real Estate Strategy
Strawberry Fields REIT, a self-administered REIT focused on skilled nursing and healthcare properties, will present at Planet MicroCap Las Vegas 2026, offering investors insight into its portfolio of 143 facilities across ten states.
GeoVax CEO Highlights Biothreat Readiness as FIFA World Cup 2026 Approaches
GeoVax CEO David A. Dodd emphasizes the need for robust public health preparedness as the FIFA World Cup 2026 is expected to draw 6.5 million attendees amid rising infectious disease threats.
American Heart Association Launches Nation of Lifesavers to Double Cardiac Arrest Survival Rate
The American Heart Association introduces the Nation of Lifesavers initiative, featuring five real-life CPR stories to encourage bystander action and double the sudden cardiac arrest survival rate by 2030.
Springs Rejuvenation Brings Stem 3 Protocol to Austin, Offering Domestic Access to Regenerative Therapies
Springs Rejuvenation has launched its Stem 3 Protocol in Austin, Texas, providing patients with peptide therapy, exosome treatment, and advanced hair restoration under physician supervision, eliminating the need to travel abroad for these therapies.
Six Peptide Compounds Dominate 2026 Laboratory Research, Review Finds
A new review from cheat codes identifies BPC-157, TB-500, CJC-1295, Ipamorelin, Selank, and Epithalon as the most studied research peptides in preclinical literature, highlighting their potential implications for future therapeutic development.